These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15358307)

  • 81. Hepatotoxic response of perfluorooctane sulfonamide (PFOSA) in early life stage zebrafish (Danio rerio) is greater than perfluorooctane sulfonate (PFOS).
    Xuan R; Qiu X; Wang J; Liu S; Magnuson JT; Xu B; Qiu W; Zheng C
    J Hazard Mater; 2024 Jan; 461():132552. PubMed ID: 37716261
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Isolation, Identification, and Biodegradation Behaviors of a Perfluorooctane Sulfonic Acid Precursor (PreFOSs) Degrading Bacterium from Contaminated Soil].
    Zhao SY; Zhou T; Wang BH; Liang TK; Liu LF
    Huan Jing Ke Xue; 2018 Jul; 39(7):3321-3328. PubMed ID: 29962158
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Liquid chromatography-tandem mass spectrometry analysis of perfluorooctane sulfonate and perfluorooctanoic Acid in fish fillet samples.
    Paiano V; Fattore E; Carrà A; Generoso C; Fanelli R; Bagnati R
    J Anal Methods Chem; 2012; 2012():719010. PubMed ID: 22567564
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Biotransformation of N-ethyl perfluorooctanesulfonamide by rainbow trout (Onchorhynchus mykiss) liver microsomes.
    Tomy GT; Tittlemier SA; Palace VP; Budakowski WR; Braekevelt E; Brinkworth L; Friesen K
    Environ Sci Technol; 2004 Feb; 38(3):758-62. PubMed ID: 14968861
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Analytical method for biomonitoring of perfluoroalkyl acids in human urine.
    Jurado-Sánchez B; Ballesteros E; Gallego M
    Talanta; 2014 Oct; 128():141-6. PubMed ID: 25059141
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Brief Report: Plasma Concentrations of Perfluorooctane Sulfonamide and Time-to-pregnancy Among Primiparous Women.
    Whitworth KW; Haug LS; Sabaredzovic A; Eggesbo M; Longnecker MP
    Epidemiology; 2016 Sep; 27(5):712-5. PubMed ID: 27276029
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Development and characterization of a solvent extraction-gas chromatographic/mass spectrometric method for the analysis of perfluorooctanesulfonamide compounds in solid matrices.
    Tittlemier SA; Pepper K; Edwards L; Tomy G
    J Chromatogr A; 2005 Feb; 1066(1-2):189-95. PubMed ID: 15794570
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rejoinder: Understanding uncertainties in a change versus change study.
    Fitz-Simon N; Fletcher T; Armstrong B
    Epidemiology; 2013 Jul; 24(4):580-1. PubMed ID: 23732736
    [No Abstract]   [Full Text] [Related]  

  • 89. Degradation of Perfluorooctane Sulfonamide by Acinetobacter Sp. M and Its Extracellular Enzymes.
    Hao J; Wang P; Kang Y; He H; Luo H; Kim S; Niu L; Jiang H; Ma K
    Chem Asian J; 2019 Aug; 14(16):2780-2784. PubMed ID: 31207187
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Commentary: Country doctor versus epidemiologist: how uncertainty analysis can help see what is in plain view.
    Burstyn I
    Epidemiology; 2013 Jul; 24(4):577-9. PubMed ID: 23732735
    [No Abstract]   [Full Text] [Related]  

  • 91. Nested Case-Control Studies Investigating Serum Perfluorooctanoate and Perfluorooctane Sulfonate Levels and Pancreatic Ductal Adenocarcinoma in Two Cohorts.
    Zhang T; Fu S; Yu K; Albanes D; Moore SC; Purdue MP; Stolzenberg-Solomon RZ
    Environ Health Perspect; 2023 Oct; 131(10):107702. PubMed ID: 37844029
    [No Abstract]   [Full Text] [Related]  

  • 92. Vitamin D3 in plasma: quantitation by mass fragmentography.
    De Leenheer AP; Cruyl AA
    Anal Biochem; 1978 Nov; 91(1):293-303. PubMed ID: 9762111
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A method for the determination of perfluorooctanoic acid in blood and other biological samples.
    Belisle J; Hagen DF
    Anal Biochem; 1980 Jan; 101(2):369-76. PubMed ID: 7362033
    [No Abstract]   [Full Text] [Related]  

  • 94. Determination of sodium caprylate in plasma volume expanders by gas chromatography.
    Lee YC; Johnson JH
    J Chromatogr; 1986 Jun; 361():279-84. PubMed ID: 2426293
    [TBL] [Abstract][Full Text] [Related]  

  • 95. High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes.
    Predieri B; Iughetti L; Guerranti C; Bruzzi P; Perra G; Focardi SE
    Int J Endocrinol; 2015; 2015():234358. PubMed ID: 26074959
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perfluorooctane Sulfonamide Induced Autotoxic Effects on the Zebrafish Immune System.
    Chen H; Zou Y; Kang X; Yang G; Yang X; Yao Y; Magnuson JT; Cao X; Qiu W; Xu EG; Zheng C
    Environ Sci Technol; 2024 Jul; ():. PubMed ID: 38976350
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The sex-related difference in perfluorooctanoate excretion in the rat.
    Hanhijärvi H; Ophaug RH; Singer L
    Proc Soc Exp Biol Med; 1982 Oct; 171(1):50-5. PubMed ID: 7145938
    [No Abstract]   [Full Text] [Related]  

  • 98. Automatic determination of weak organic acids by partition column chromatography and indicator titration.
    Kesner L; Muntwyler E
    Anal Chem; 1966 Aug; 38(9):1164-8. PubMed ID: 5939125
    [No Abstract]   [Full Text] [Related]  

  • 99. Associations among perfluorooctanesulfonic/perfluorooctanoic acid levels, nuclear receptor gene polymorphisms, and lipid levels in pregnant women in the Hokkaido study.
    Kobayashi S; Sata F; Goudarzi H; Araki A; Miyashita C; Sasaki S; Okada E; Iwasaki Y; Nakajima T; Kishi R
    Sci Rep; 2021 May; 11(1):9994. PubMed ID: 33976266
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values.
    Chou WC; Lin Z
    Environ Health Perspect; 2021 Mar; 129(3):37004. PubMed ID: 33730865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.